Oncology Today with Dr Neil Love

Dr John Heymach on Angiogenesis Inhibition in Lung Cancer and COVID-19 at MD Anderson

August 1st, 2020  •  15 mins 34 secs  •  Download (14.3 MB)  •  Link with Timestamp

RSS Feed

Dr John Heymach from the MD Anderson Cancer Center discusses the role of anti-angiogenic agents in NSCLC and the status of clinical research for and treatment of lung cancer at MD Anderson during the COVID-19 pandemic.